Liminal BioSciences Announces FDA Extension of Review Period for Ryplazim®(plasminogen) BLA ...Middle East

PDUFA date extended by FDA from March 5, 2021 to June 5, 2021 Earnings call moved forward to Wednesday November 11th LAVAL, QC, and CAMBRIDGE, England, Nov. 8, 2020 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage...

Read More Details
Finally We wish PressBee provided you with enough information of ( Liminal BioSciences Announces FDA Extension of Review Period for Ryplazim®(plasminogen) BLA )

Also on site :

• Muir says controversial Belfast bonfire should not be set alight
• Man dies at Hamburg station after being dragged by train
• 'The last thing we wanted' - Shropshire beauty spot to remain closed this heatwave weekend due to toxic algae